A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese Ethnicity

Clinical trial NCT06411730 · COMPLETED

Trial details

NCT number: NCT06411730
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-05-31
Primary completion: 2024-10-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.